Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicentre, Randomized, Unblinded Clinical Trial to Test the Effect of Treatment with Recombinant LH Prior to Controlled Ovarian Stimulation in Poor Ovarian Responder Women with an Advanced Maternal Age

NCT03741699 is registered in ClinicalTrials.gov with Instituto Valenciano de Infertilidad, IVI Alicante as lead sponsor.

NCT NCT03741699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicentre, Randomized, Unblinded Clinical Trial to Test the Effect of Treatment with Recombinant LH Prior to Controlled Ovarian Stimulation in Poor Ovarian Responder Women with an Advanced Maternal Age
Lead sponsor
Instituto Valenciano de Infertilidad, IVI Alicante
Phase
Phase 3
Overall status
Completed
Start date
February 18, 2019
Completion date
May 11, 2024
Enrollment
88 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female